Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration-Reference-Cited by-同舟云学术

Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration

Published:2016-04 Issue: Volume:145 Page:248-257
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Lambert Nathan G.^ORCID,Zhang Xiaohui,Rai Ruju R.,Uehara Hironori,Choi Susie,Carroll Lara S.,Das Subrata K.,Cahoon Judd M.,Kirk Brian H.,Bentley Blaine M.,Ambati Balamurali K.^ORCID

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference101 articles.

1. Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness;Amado;Sci. Transl. Med.,2010

2. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA;Ashikari;Invest. Ophthalmol. Vis. Sci.,2010

3. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system;Augustin;Nat. Rev. Mol. Cell Biol.,2009

4. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules;Baffert;Am. J. Physiol. Heart Circ. Physiol.,2006

5. AAV2 gene therapy readministration in three adults with congenital blindness;Bennett;Sci. Transl. Med.,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches in the Drug Development and Delivery Systems for Age-Related Macular Degeneration;Life;2023-02-17

2. Research Progress of Signal Pathways Related to Age-Related Macular Degeneration;Advances in Clinical Medicine;2023

3. Subretinal injection in mice to study retinal physiology and disease;Nature Protocols;2022-04-13

4. The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons;Translational Vision Science & Technology;2022-03-11

5. COMP-Ang1: Therapeutic potential of an engineered Angiopoietin-1 variant;Vascular Pharmacology;2021-12